Powers Advisory Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$579K Sell
5,589
-104
-2% -$11.8K 0.2% 68
2025
Q4
$574K Sell
5,693
-348
-6% -$37.8K 0.22% 67
2025
Q3
$745K Sell
6,041
-509
-8% -$63.2K 0.3% 54
2025
Q2
$786K Sell
6,550
-180
-3% -$24K 0.35% 47
2025
Q1
$991K Sell
6,730
-21
-0.3% -$3.21K 0.47% 38
2024
Q4
$1.1M Buy
6,751
+33
+0.5% +$5.4K 0.55% 31
2024
Q3
$1.09M Buy
6,718
+20
+0.3% +$2.96K 0.55% 31
2024
Q2
$914K Buy
6,698
+5
+0.1% +$694 0.5% 35
2024
Q1
$1.02M Buy
6,693
+10
+0.1% +$1.49K 0.59% 32
2023
Q4
$953K Sell
6,683
-71
-1% -$9.47K 0.59% 32
2023
Q3
$885K Buy
6,754
+34
+0.5% +$5.17K 0.6% 33
2023
Q2
$1.07M Sell
6,720
-37
-0.5% -$5.97K 0.71% 30
2023
Q1
$1.07M Buy
6,757
+34
+0.5% +$5.1K 0.75% 30
2022
Q4
$943K Buy
6,723
+52
+0.8% +$7.38K 0.7% 34
2022
Q3
$856K Buy
6,671
+173
+3% +$25K 0.68% 34
2022
Q2
$916K Sell
6,498
-218
-3% -$31.1K 0.7% 32
2022
Q1
$934K Buy
6,716
+371
+6% +$56.9K 0.65% 36
2021
Q4
$1.11M Buy
+6,345
New +$1.06M 0.78% 29

Other funds holding CLX

Powers Advisory Group's CLX Position: Q1 2026 in Review

Powers Advisory Group reduced its Clorox (CLX) stake by 1.8% in Q1 2026, selling an estimated $11.8K and leaving 5,589 shares worth $579K. The position accounts for 0.2% of the portfolio, ranked #68.

Powers Advisory Group first reported a position in CLX in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.11M in Q4 2021. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Powers Advisory Group held 5,589 shares of Clorox worth $579K as of Q1 2026.
  • Powers Advisory Group sold 104 Clorox shares in Q1 2026, an estimated $11.8K.
  • Clorox made up 0.2% of Powers Advisory Group's portfolio in Q1 2026, its #68 holding.
  • Powers Advisory Group first reported a position in Clorox in Q4 2021 and has held it in 18 quarters since.
  • Powers Advisory Group's Clorox position peaked at $1.11M in Q4 2021.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Powers Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.